235 related articles for article (PubMed ID: 11241346)
1. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.
Greco O; Dachs GU
J Cell Physiol; 2001 Apr; 187(1):22-36. PubMed ID: 11241346
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
3. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.
Connors TA
Gene Ther; 1995 Dec; 2(10):702-9. PubMed ID: 8750009
[TBL] [Abstract][Full Text] [Related]
4. Strategies for enzyme/prodrug cancer therapy.
Xu G; McLeod HL
Clin Cancer Res; 2001 Nov; 7(11):3314-24. PubMed ID: 11705842
[TBL] [Abstract][Full Text] [Related]
5. Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer.
Khatri A; Russell PJ
Discov Med; 2007 Feb; 7(37):39-45. PubMed ID: 17343804
[TBL] [Abstract][Full Text] [Related]
6. From bench to bedside for gene-directed enzyme prodrug therapy of cancer.
Dachs GU; Tupper J; Tozer GM
Anticancer Drugs; 2005 Apr; 16(4):349-59. PubMed ID: 15746571
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.
Both GW
Curr Opin Mol Ther; 2009 Aug; 11(4):421-32. PubMed ID: 19649987
[TBL] [Abstract][Full Text] [Related]
8. Prodrug activation enzymes in cancer gene therapy.
Aghi M; Hochberg F; Breakefield XO
J Gene Med; 2000; 2(3):148-64. PubMed ID: 10894261
[TBL] [Abstract][Full Text] [Related]
9. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs in cancer chemotherapy.
Connors TA; Knox RJ
Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
[TBL] [Abstract][Full Text] [Related]
11. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
12. Suicide gene therapy using E. coli beta-galactosidase.
Farquhar D; Pan BF; Sakurai M; Ghosh A; Mullen CA; Nelson JA
Cancer Chemother Pharmacol; 2002 Jul; 50(1):65-70. PubMed ID: 12111114
[TBL] [Abstract][Full Text] [Related]
13. Current progress in suicide gene therapy for cancer.
Yazawa K; Fisher WE; Brunicardi FC
World J Surg; 2002 Jul; 26(7):783-9. PubMed ID: 11948367
[TBL] [Abstract][Full Text] [Related]
14. Prodrugs in genetic chemoradiotherapy.
Patterson AV; Saunders MP; Greco O
Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
[TBL] [Abstract][Full Text] [Related]
15. Imaging beyond the diagnosis: image-guided enzyme/prodrug cancer therapy.
Tong X; Chen X; Li C
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):4-12. PubMed ID: 21134886
[TBL] [Abstract][Full Text] [Related]
16. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
[TBL] [Abstract][Full Text] [Related]
17. Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer.
Knox RJ
Curr Opin Investig Drugs; 2001 Jun; 2(6):835-8. PubMed ID: 11572666
[No Abstract] [Full Text] [Related]
18. Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.
Vajda A; Marignol L; Foley R; Lynch TH; Lawler M; Hollywood D
Cancer Treat Rev; 2011 Dec; 37(8):643-54. PubMed ID: 21481534
[TBL] [Abstract][Full Text] [Related]
19. Gene-directed enzyme prodrug therapy: a current assessment.
McKeown SR; Ward C; Robson T
Curr Opin Mol Ther; 2004 Aug; 6(4):421-35. PubMed ID: 15468601
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
Wallace PM; Senter PD
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]